NAGE Stock-Based Compensation
Niagen Bioscience Inc · Stock-Based Compensation
NAGE Stock-Based Compensation
Latest reported$6.94Mperiod ending
NAGE TTM Stock-Based Comp ($0.00 → $6.94M)
TTM stock-based compensation
High-resolution chart · PNG
NAGE stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 6,943,000 | |
| 6,708,000 | |
| 6,067,000 | |
| 5,071,000 | |
| 4,050,000 | |
| 3,747,000 | |
| 3,656,000 | |
| 3,941,000 | |
| 4,323,000 | |
| 4,462,000 | |
| 4,751,000 | |
| 5,040,000 | |
| 5,152,000 | |
| 5,124,000 | |
| 5,739,000 | |
| 5,886,000 | |
| 6,479,000 | |
| 6,799,000 | |
| 6,195,000 | |
| 6,500,000 | |
| 6,252,000 | |
| 6,347,000 | |
| 6,936,000 | |
| 6,856,000 | |
| 6,968,000 | |
| 7,016,000 | |
| 7,172,000 | |
| 7,459,000 | |
| 7,090,000 | |
| 7,142,000 | |
| 6,371,000 | |
| 7,780,241 | |
| 6,954,241 | |
| 5,543,241 | |
| 4,605,241 | |
| 1,474,756 | |
| 1,256,145 | |
| 1,189,747 | |
| 1,193,782 | |
| 1,251,133 | |
| 1,412,071 | |
| 1,585,737 | |
| 1,977,611 | |
| 2,105,708 | |
| 2,103,832 | |
| 2,633,172 | |
| 2,916,924 | |
| 2,695,984 | |
| 2,595,837 | |
| 1,935,988 | |
| 1,287,917 | |
| 1,572,989 | |
| 2,167,078 | |
| 2,988,856 | |
| 2,703,253 | |
| 2,689,240 | |
| 2,727,951 | |
| 2,298,118 | |
| 2,969,150 | |
| 3,025,677 | |
| 2,485,337 | |
| 1,947,491 | |
| 1,262,071 | |
| 758,340 | |
| 390,523 | |
| 210,495 | |
| 205,858 | |
| 153,739 | |
| 97,792 | |
| 46,962 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |